Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content
MRI Access

MRI ACCESS Implantable Cardiac Devices

Cardiology and Radiology

Unmatched MRI Access

Annually, 12-16% of device patients are likely to have an MRI ordered.1-4 Historically, less than 1% would have received a scan.1-4 Today, with our exclusive MRI portfolio, you can ensure safe MRI access for the most patients when MR conditions are met.

Medtronic has long been committed to providing cardiac device patients with access to the diagnostic and treatment benefits of MRI. Our portfolio of SureScan™ cardiac resynchronization therapy pacemaker (CRT-P), cardiac resynchronization therapy defibrillator (CRT-D), implantable cardioverter defibrillator (ICD), pacemakers (IPG), and insertable cardiac monitor (ICM) systems provides exactly that — safe, full body MRI access.

  • No MRI exclusion zone
  • SureScan devices and leads that work in any combination
  • 1.5T and 3T full body MRI scanning across the portfolio*

*Revo MRI™ pacemaker is only labeled 1.5T MR Conditional.

pdf MR-Conditional Cardiac Device Summary Chart (.pdf)

For a full listing of our implantable cardiac devices that are approved for use in the MR environment, download our MR-Conditional Cardiac Device Summary Chart.

276KB

MR-Conditional Cardiac Device Summary Chart
1

Data from 2010 MarketScan® Commercial and Medicare databases from Truven Health Analytics, Inc. were used to characterize non-pacemaker and pacemaker cohorts and utilization or radiology services. Cohorts were matched based on age, gender, and comorbidities.

2

Medtronic data on file 2015: ICD data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.

3

Nazarian S, Reynolds MR, Ryan MP, et al. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. January 2016;43(1):115-127.

4

Medtronic data on file 2015: CRT data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.